In the NSCLC cell line A549, CVM-1125 reduces cytosolic succinate levels and causes destabilization of HIF-1α by targeting TRAP1, thereby blocking its downstream signaling and ultimately inducing mitochondrial apoptosis, inhibiting tumor cell growth, and suppressing angiogenic mimicry (122). Here, TRAP1 is linked to neoplasm.